Open access · US-GOV
via ClinicalTrials.gov Clinical trial
A Prospective, Study Evaluating the Efficacy of DOSE Formulations in Treatment of Melasma and Cutaneous Signs of Aging
Authors not listed
Goldman, Butterwick, Fitzpatrick and Groff · 2019
Abstract
The primary objective is to evaluate the efficacy, of D.O.S.E formulations in the treatment of melasma and cutaneous signs of aging.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-05-31 MST
Cite this
APA
Anonymous. (2019). A Prospective, Study Evaluating the Efficacy of DOSE Formulations in Treatment of Melasma and Cutaneous Signs of Aging. <em>Goldman, Butterwick, Fitzpatrick and Groff</em>. https://clinicaltrials.gov/study/NCT04137263
Vancouver
Anonymous. A Prospective, Study Evaluating the Efficacy of DOSE Formulations in Treatment of Melasma and Cutaneous Signs of Aging. Goldman, Butterwick, Fitzpatrick and Groff. 2019.
BibTeX
@misc{anon2019AProsp,
title = {A Prospective, Study Evaluating the Efficacy of DOSE Formulations in Treatment of Melasma and Cutaneous Signs of Aging},
author = {Anonymous},
journal = {Goldman, Butterwick, Fitzpatrick and Groff},
year = {2019},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
1998
Citation only
Successful Aging
Kenvue Brands LLC 2025
Open access · US-GOV
Eight-Week, Single-Site Study to Evaluate the Efficacy of a Facial Sunscreen in Adult Participants With Oily Skin and Signs of Aging
Cells 2026
Open access · OA
Mitofusin Activation Delays Aging in Caenorhabditis elegans
Steven Baker 2020
Open access · US-GOV
Study to Evaluate the Efficacy of the décoLITE LED Device in Treating the Signs of Skin Aging of the décolletage Area
The Foundation for Orthopaedics and Regenerative Medicine 2022
Open access · US-GOV
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Aging Frailty
BioAge Labs, Inc. 2021
Open access · US-GOV